Ipci Kagan, Altıntoprak Niyazi, Muluk Nuray Bayar, Senturk Mehmet, Cingi Cemal
ENT Clinics, Ankara Koru Hospital, Ankara, Turkey.
ENT Clinics, Tuzla State Hospital, Istanbul, Turkey.
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):617-626. doi: 10.1007/s00405-016-4058-6. Epub 2016 Apr 26.
In the present paper, we discuss the importance of the microbiome in allergic disease. In this review paper, the data from the Medline (PubMed) and search engine of Kirikkale University were systematically searched for all relevant articles in June 15th, 2015 for the past 30 years. The keywords of "microbiome", "dysbiosis", "allergy", "allergic rhinitis", "allergic disease", "mechanisms" and "treatment" were used alone or together. In this paper, microbiomes were presented in terms of "Definition", "Influence of \the human microbiome on health", "The microbiome and allergic diseases", and "Modulation of the gut microbiota in terms of treatment and prevention". Microbiological dysbiosis is also reviewed. The microbiome is the genetic material of all microbes (bacteria, fungi, protozoa, and viruses) that live on or in the human body. Microbes outnumber human cells in a 10:1 ratio. Most microbes live in the gut, particularly the large intestine. Changes in the immune function of the respiratory tract are (at least in theory) linked to the immunomodulatory activity of the gut microbiota via the concept of a "common mucosal response". The gut microbiota shapes systemic immunity, thus affecting the lung mucosa. Alternatively, changes in the gut microbiota may reflect alterations in the oropharyngeal microbiota, which may in turn directly affect the lung microbiota and host immune responses via microaspiration. Dysbiosis is defined as qualitative and quantitative changes in the intestinal flora; and modern diet and lifestyle, antibiotics, psychological and physical stress result in alterations in bacterial metabolism, as well as the overgrowth of potentially pathogenic microorganisms. All immune system components are directly or indirectly regulated by the microbiota. The nature of microbial exposure early in life appears to be important for the development of robust immune regulation; disruption of either the microbiota or the host response can trigger chronic inflammation. Dysbiosis is also an important clinical entity. Antibiotics, psychological and physical stress, and dietary factors contribute to intestinal dysbiosis.
在本论文中,我们讨论了微生物群落在过敏性疾病中的重要性。在这篇综述论文中,于2015年6月15日系统性地检索了Medline(PubMed)和基里克勒大学搜索引擎中过去30年的所有相关文章。单独或组合使用了“微生物群落”“生态失调”“过敏”“过敏性鼻炎”“过敏性疾病”“机制”和“治疗”等关键词。本文从“定义”“人类微生物群落对健康的影响”“微生物群落与过敏性疾病”以及“从治疗和预防角度对肠道微生物群的调节”等方面阐述了微生物群落。还对微生物生态失调进行了综述。微生物群落是指生活在人体上或体内的所有微生物(细菌、真菌、原生动物和病毒)的遗传物质。微生物与人体细胞的数量比为10:1。大多数微生物生活在肠道,尤其是大肠。呼吸道免疫功能的变化(至少在理论上)通过“共同黏膜反应”的概念与肠道微生物群的免疫调节活性相关联。肠道微生物群塑造全身免疫,从而影响肺黏膜。或者,肠道微生物群的变化可能反映口咽微生物群的改变,而口咽微生物群的改变可能反过来通过微吸入直接影响肺微生物群和宿主免疫反应。生态失调被定义为肠道菌群的定性和定量变化;现代饮食和生活方式、抗生素、心理和身体压力会导致细菌代谢改变以及潜在致病微生物的过度生长。所有免疫系统成分都直接或间接受微生物群调节。生命早期接触微生物的性质似乎对强大的免疫调节的发展很重要;微生物群或宿主反应的破坏都可能引发慢性炎症。生态失调也是一个重要的临床实体。抗生素、心理和身体压力以及饮食因素都会导致肠道生态失调。